This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Sova Pharmaceuticals, Inc.. Active years: 2017-2019.
Company Filing History:
Years Active: 2017-2019
Title: The Innovative Contributions of Simon G Sydserff
Introduction
Simon G Sydserff is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit cystathionine-gamma-lyase (CSE). With a total of three patents to his name, Sydserff's work is paving the way for new treatments for various diseases.
Latest Patents
Sydserff's latest patents focus on CSE inhibitors. These patents describe compounds and pharmaceutical compositions that inhibit cystathionine-gamma-lyase (CSE). The methods outlined in these patents detail how these CSE inhibitors can be used, either alone or in combination with other compounds, to treat diseases or conditions that would benefit from CSE inhibition.
Career Highlights
Sydserff is currently associated with Sova Pharmaceuticals, Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has garnered attention in the scientific community, contributing to advancements in medical treatments.
Collaborations
Some of his notable coworkers include Sergio G Durón and Justin Chapman. Their collaborative efforts enhance the research and development processes at Sova Pharmaceuticals, Inc.
Conclusion
Simon G Sydserff's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work on CSE inhibitors is particularly promising for future medical applications.